SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis
Molecular Cell · 2025-03 · 85 (5) · 894-912.e10
DOI: 10.1016/j.molcel.2025.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-03. Verfasst von Akane Ogawa und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan. Hauptthemen laut MEDLINE: Apoptosis, Tumor Suppressor Protein p53, Ribosomes, Nuclear Proteins. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Japan Society for the Promotion of Science, Keio University.
Abstract (Originalsprache)
Impairment of ribosome biogenesis (RiBi) triggered by inhibition of ribosomal RNA (rRNA) synthesis and processing leads to various biological effects. We report that Schlafen 11 (SLFN11) induces TP53-independent apoptosis through RiBi impairment. Upon replication stress, SLFN11 inhibits rRNA synthesis with RNA polymerase I accumulation and increased chromatin accessibility in the ribosomal DNA (rDNA) genes. SLFN11-dependent RiBi impairment preferentially depletes short-lived proteins, particularly MCL1, leading to apoptosis in response to replication stress. SLFN11's Walker B motif (E669), DNA-binding site (K652), dephosphorylation site for single-strand DNA binding (S753), and RNase sites (E209/E214) are all required for the SLFN11-mediated RiBi impairment. Comparable effects were obtained with direct RNA polymerase I inhibitors and other RiBi inhibitory conditions regardless of SLFN11. These findings were extended across 34 diverse human cancer cell lines. Thus, we demonstrate that RiBi impairment is a robust inactivator of MCL1 and an additional proapoptotic mechanism by which SLFN11 sensitizes cancer cells to chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan.
- Laboratory of Molecular and Cellular Biochemistry, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
- Division of Cell Growth and Tumor Regulation, Proteo-Science Center, Toon, Ehime 791-0295, Japan; Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Ja…
- Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
- Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.
- Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20814, USA.
Förderung
- Intramural NIH HHS
- Japan Society for the Promotion of Science
- Keio University
- Japan Science and Technology Agency
- Ehime University
- Kyoto University
- National Cancer Center Japan
- National Cancer Institute
Zitieren
APA
Ogawa, A., Izumikawa, K., Tate, S., Isoyama, S., Mori, M., Fujiwara, K., Watanabe, S., Ohga, T., Jo, U., Taniyama, D., Kitajima, S., Tanaka, S., Onji, H., Kageyama, S. I., Yamamoto, G., Saito, H., Morita, T. Y., Okada, M., Natsumeda, M., …, & Murai, J. (2025). SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis. Molecular Cell, 85(5), 894-912.e10. https://doi.org/10.1016/j.molcel.2025.01.008
Vancouver
Ogawa A, Izumikawa K, Tate S, Isoyama S, Mori M, Fujiwara K, et al. SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis. Molecular Cell. 2025;85(5):894-912.e10. doi:10.1016/j.molcel.2025.01.008
BibTeX
@article{Ogawa2025,
author = {Ogawa, Akane and Izumikawa, Keiichi and Tate, Sota and Isoyama, Sho and Mori, Masaru and Fujiwara, Kohei and Watanabe, Soyoka and Ohga, Takayuki and Jo, Ukhyun and Taniyama, Daiki and Kitajima, Shojiro and Tanaka, Soichiro and Onji, Hiroshi and Kageyama, Shun-Ichiro and Yamamoto, Gaku and Saito, Hitoshi and Morita, Tomoko Yamamori and Okada, Masayasu and Natsumeda, Manabu and Nagahama, Masami and Kobayashi, Junya and Ohashi, Akihiro and Sasanuma, Hiroyuki and Higashiyama, Shigeki and Dan, Shingo and Pommier, Yves and Murai, Junko},
title = {SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {5},
pages = {894--912.e10},
doi = {10.1016/j.molcel.2025.01.008}
}
EUVIMED